Houston biotech cos. begin clinical trials for cancer, Covid-19 treatments
Both Iterion and Moleculin are moving their drug candidates through the regulatory pipeline.
Read More
Building "Bridges" Across the Bayou City!
Both Iterion and Moleculin are moving their drug candidates through the regulatory pipeline.
Read MoreBoth Iterion and Moleculin are moving their drug candidates through the regulatory pipeline.
Read MoreSportsMap Tech Acquisition Corp. (Nasdaq: SMAPU), a Houston-based special purpose acquisition company focused on deals in the sports tech space, priced a $100 million initial public offering on Oct. 18 and began trading on the Nasdaq on Oct. 19.
Read MoreDuring March and April 2020, employers in the Houston metro region shed more than 361,000 nonfarm jobs, or about one in every nine jobs in the region.
Read MoreMore than 1,000 different names were considered before whittling the list down to five of the most welcoming brand names, based on consumer research.
Read MoreCadence also announced details for a special dividend that’s expected to result in a distribution of approximately $153 million.
Read MoreCompanies in Houston are operating in several parts of the hemp and medical marijuana value chain.
Read MoreCart.com has raised more than $140 million since launching in November 2020.
Read MoreThis year, the mayor’s annual address was hosted by Houston First Corp. after Turner canceled his event with the Greater Houston Partnership in May.
Read MoreA local labor and employment lawyer says companies can comply with both Abbott’s executive order and federal mandates.
Read More